“Adjuvant Nivolumab in Resected Oesophageal or Gastroesophageal Junction Cancer Following Neoadjuvant Chemoradiotherapy: Slove-Nian Real-World Data”. Radiology and Oncology, vol. 60, no. 2, July 2026, pp. 288-93, https://www.radioloncol.com/index.php/ro/article/view/4731.